Candela Receives Additional Clearance for Its Serenity Device

Candela Corporation announced it received an additional FDA clearance for its Serenity device using pneumatic skin flattening (PSF) technology, the first system of its type to receive clearance for pain reduction, according to the company.

This clearance enables the use of the Serenity device for the reduction of pain during all laser and intense pulse light treatments.

Patients often discontinue their aesthetic laser treatments because of pain, Candela said. The PSF technology relies on the Gate theory for pain reduction, which inhibits the transmission of pain signals to the brain, making treatments more tolerable, it said.

The company obtained the PSF technology through its acquisition of Inolase last March.